July 19, 2019
Endo Pharmaceuticals Inc. has agreed to pay $2.3 million to 18 states in a deal reached Friday, the same day the states hit the pharmaceutical company with a suit alleging it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch.